MedTech Valuation, Inc. Launches Opportunity Assessment Models to Streamline Early Stage Market Sizing

Sophisticated and Surprisingly Intuitive Models Free of Charge for Registered Customers

Fort Lauderdale, FL - January 5, 2018 - MedTech Valuation, Inc., launches a series of opportunity evaluation models FREE OF CHARGE for registered customers at their website.  The first of these focuses on forecasting future revenue for a pre-commercial pharmaceutical, and became available today.

"Identifying qualified potential opportunities is one of the most challenging steps in the business development process.  You have to kiss an awful lot of frogs to find a prince (or princess)!  We want our customers to know we are committed to bringing them value and these opportunity evaluation forecasts will significantly improve their opportunity screening process and reduce the burden of early stage financial forecasting," commented Michael Kubica, President of MedTech Valuation.  Alice Fortson, a seasoned business development professional in the pharmaceutical industry said "I've seen companies charge thousands of dollars for models that are less sophisticated and far more difficult to use.  This is going to save me a lot of time when considering which opportunities are worth pursuing further!"


The company will also launch opportunity screening models structured for disposable surgical devices (with and without durable equipment, such as energy products), implantable medical devices and diagnostics technologies.  Access to these resources is free of charge for any customers registered on their website at

About MedTech Valuation, Inc.

MedTech Valuation, Inc. is an industry leader in helping life science companies and capital investment agencies identify, understand and articulate the value of novel and inline medical technologies.


Michael Kubica